Patients Eagerly Awaited a Generic Drug. Then They Saw the Price.

Teva Pharmaceuticals announced it would sell a “lower-cost” alternative to Syprine, an old drug that costs more than $21,000. But the new generic version costs nearly as much.

Topics:  health   
RELATED ARTICLES
    BING NEWS:
    • US drug shortages reach all-time high: Cancer and diabetes patients waiting 'deadly' amount of time for lifesaving drugs
      David Gaugh, interim president and CEO of the Association for Accessible Medicines, told Axios: ‘The majority of generic drug shortages cannot be addressed without raising prices.’ The global ...
      04/11/2024 - 7:28 am | View Link
    • ALS drug will be pulled from US market after study showed patients didn't benefit
      WASHINGTON — (AP) — The maker of a drug for Lou Gehrig's disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn't help ...
      04/4/2024 - 9:07 am | View Link
    • Stroke drug ARG-007 offers hope to patients
      Followed categories will be added to My News. The Aussie drug does not aim to stop the stroke but instead buy patients critical extra time to get help, protecting their brain from damage until ...
      04/3/2024 - 1:36 pm | View Link
    • More

     

    Welcome to Wopular!

    Welcome to Wopular

    Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

    Senh Duong (Founder)
    Wopular, MWB, RottenTomatoes

    Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

    MoviesWithButter : Our Sister Site

    More Health News